Transaction · 0001750495-26-000007

Trombley Aetna Wun

Trombley Aetna Wun, PRES, reported a transaction classified as grant at Lycia Therapeutics, Inc. involving 443586.000000 shares for an estimated $0.00. Reported holdings after the transaction were 443586.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code APRES
LYCALycia Therapeutics, Inc.
Trade date
Aug 11, 2026
Filing date
Oct 26, 2026
View on SEC Insider profile
Disclosed value$0Shares × reported price
Shares traded443k$0.00 per share
Holdings after443kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 76 calendar days after the transaction date.

LYCA price since this filing

Daily closing prices, with the filing date and available return windows
LYCA · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001750495-26-000007
Stock Option (Right to Buy)
Transaction date
Aug 11, 2026
Filed Oct 26, 2026, 10:56 PM · 76d delay
Shares
443,586 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
443,586 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Delayed Filing Derivative Transaction Direct Ownership Large Holdings Increase
Filing-only score

-16 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
  • delayed_filing-6 points

    reporting_delay_days = 76

    Filing delay exceeds the configured threshold.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President and CEO

Officer YesDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    The transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Exchange Act in connection with the Issuer's initial public offering, and the transa…

  2. F2

    The options vest as to 1/48 of the total award monthly over four years, with the first tranche vested on September 6, 2026, subject to the Reporting Person's provision of service to the Issuer on each…

Original filing · 0001750495-26-000007
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

LYCA